Fundraise / allotmentFiled on BSE ·
Natco Pharma to hold Board meeting on 25 Sept 2026 for Rights Issue details
Natco Pharma · Pharmaceuticals & Biotechnology
What the filing says
- Board meeting scheduled on 25th September 2026 to decide terms of Rights Issue
- Rights Issue approved for up to ₹1,300 crore via equity shares of ₹2 face value
- Trading window closure for designated persons from 23rd Sept 2026 until 48 hours post outcome disclosure
Original filing
Board Meeting Intimation for Rights Issue Of Equity Shares
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue: Rank 1Margin: Rank 1
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Natco Pharma
- Fundraise / allotmentNATCO Pharma Limited files Letter of Offer for Rights Issue closing Oct 22, 2026
- Fundraise / allotmentNatco Pharma approves ₹1279.35 crore rights issue of 1.70 crore equity shares
- Fundraise / allotmentNATCO Pharma Limited sets record date for Rights Issue on October 1, 2026
- Fundraise / allotmentNatco Pharma approves ₹1279.36 crore rights issue and amends trading code
- Fundraise / allotmentNatco Pharma Limited receives in-principle approval for Rights Issue
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentInox GreenInox Green Energy Services Ltd allotted 1.81 crore equity shares via QIP in Sept 2026
- Fundraise / allotmentInox GreenInox Green Energy Services completes Qualified Institutions Placement on Sept 29, 2026
- Fundraise / allotmentBharat Parenterals LtdBharat Parenterals Limited approves preferential allotment of 9.13 lakh equity shares
- Fundraise / allotmentAurum Proptech LtdAurum PropTech allots 1.98 crore equity shares to REA India on preferential basis
- Fundraise / allotmentAurum Proptech LtdAurum PropTech Limited allots 1.98 crore shares to REA India on preferential basis
- Fundraise / allotmentRepco Home FinRepco Home Finance approved raising ₹1500 Cr NCDs and ₹1000 Cr Commercial Paper
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.